Manchester Financial’s Gilead Sciences GILD Stock Holding History

Manchester Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,212	Closed	-$356K	–	133
2025 Q2	$356K	Hold	3,212	–	–	0.07%	88
2025 Q1	$360K	Hold	3,212	–	–	0.08%	77
2024 Q4	$297K	Hold	3,212	–	–	0.06%	88
2024 Q3	$269K	Hold	3,212	–	–	0.06%	91
2024 Q2	$220K	Hold	3,212	–	–	0.05%	95
2024 Q1	$235K	Hold	3,212	–	–	0.06%	86
2023 Q4	$260K	Hold	3,212	–	–	0.07%	81
2023 Q3	$241K	Hold	3,212	–	–	0.07%	79
2023 Q2	$248K	Hold	3,212	–	–	0.07%	80
2023 Q1	$267K	Hold	3,212	–	–	0.08%	76
2022 Q4	$276K	Buy	+3,212	New	+$254K	0.07%	74
2021 Q2	–	Sell	-128	Closed	-$8K	–	287
2021 Q1	$8K	Buy	128 +1	+0.8%	+$64	﹤0.01%	465
2020 Q4	$7K	Sell	127 -19	-13%	-$1.15K	﹤0.01%	413
2020 Q3	$9K	Hold	146	–	–	0.01%	325
2020 Q2	$11K	Buy	146 +126	+630%	+$9.66K	0.01%	299
2020 Q1	$1K	Sell	20 -45	-69%	-$3.11K	﹤0.01%	462
2019 Q4	$4K	Buy	+65	New	+$4.23K	﹤0.01%	448
2019 Q3	–	Sell	-227	Closed	-$15K	–	193
2019 Q2	$15K	Buy	+227	New	+$14.9K	0.01%	280

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Manchester Financial's GILD Position: Q3 2025 in Review

Manchester Financial sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,212 shares — an estimated $356K sold.

Manchester Financial first reported a position in GILD in Q2 2019 and held it in 18 quarters. The position peaked at $360K in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

Manchester Financial reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
Manchester Financial sold 3,212 Gilead Sciences shares in Q3 2025, an estimated $356K.
Manchester Financial first reported a position in Gilead Sciences in Q2 2019 and held it in 18 quarters.
Manchester Financial's Gilead Sciences position peaked at $360K in Q1 2025.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Manchester Financial's 13F filing for Q3 2025, filed 15 Oct 2025.